Biosimilars to Lead to $192 Billion Loss for Originators by 2028
January 18th 2024IQVIA’s most recent Global Use of Medicines report projected that market introductions of new biosimilar and generic drugs will increase projected losses for originator products from $111 billion to $192 billion over the next five years.